The Prevalence of Potential Drug-Drug Interactions in Patients with Heart Failure at Hospital Discharge

被引：0
|
作者：
Bernhard Straubhaar
Stephan Krähenbühl
Raymond G. Schlienger
机构：
[1] University of Basel,Department of Pharmaceutical Sciences, Institute of Clinical Pharmacy
[2] University Hospital of Basel,Division of Clinical Pharmacology and Toxicology
来源：
Drug Safety | 2006年 / 29卷
关键词：
Amiodarone; International Normalise Ratio; Heart Failure Patient; Carvedilol; Spironolactone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background/objective: Pharmacotherapy for heart failure is complex and, due to polypharmacy, is associated with a large risk of potential drug-drug interactions (DDIs). The objective of the present study was to assess the prevalence of potential DDIs in the medication of hospitalised heart failure patients and to evaluate their clinical relevance.
引用
收藏
页码：79 / 90
页数：11
相关论文
共 50 条
  • [1] The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge
    Straubhaar, B
    Krähenbühl, S
    Schlienger, RG
    DRUG SAFETY, 2006, 29 (01) : 79 - 90
  • [2] Potential drug-drug interactions in the medication of medical patients at hospital discharge
    Egger, SS
    Drewe, J
    Schlienger, RG
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (11) : 773 - 778
  • [3] Assessment of potential drug-drug interactions at hospital discharge
    Bertoli, R.
    Bissig, M.
    Caronzolo, D.
    Odorico, M.
    Pons, M.
    Bernasconi, E.
    SWISS MEDICAL WEEKLY, 2010, 140
  • [4] POTENTIAL DRUG-DRUG INTERACTIONS IN PSYCHIATRIC PATIENTS DURING HOSPITALIZATION AND AT HOSPITAL DISCHARGE
    Todorova-Nenova, Koraliya
    Zhelyazkova-Savova, Maria
    Gancheva, Silvia
    Stoychev, Elitsa
    JOURNAL OF IMAB, 2022, 28 (01): : 4223 - 4228
  • [5] Prevalence of potential drug-drug interactions during hospital discharge in a tertiary care center in Nepal
    Bhandari, Bijay
    Lamichhane, Pratik
    Yadav, Dipendra
    Bajracharya, Sangha Ratna
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 496 - 496
  • [6] Prevalence of potential drug-drug interactions during hospital discharge in a tertiary care center in Nepal
    Bhandari, Bijay
    Lamichhane, Pratik
    Yadav, Dipendra
    Bajracharya, Sangha Ratna
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (06) : 1204 - 1204
  • [7] PREVALENCE OF HYPERTENSION AND POTENTIAL DRUG-DRUG INTERACTIONS AMONG CHRONIC HEART FAILURE PATIENTS MANAGED AT LAGOS UNIVERSITY TEACHING HOSPITAL, NIGERIA
    Ofonakara, Uzochukwu
    Olayemi, Samuel
    Ale, Kolawale
    CHEST, 2019, 156 (04) : 39A - 39A
  • [8] Predictors of potential clinically significant drug-drug interactions in patients with heart failure.
    Kovacevic, Milena
    Kovacevic, Sandra Vezmar
    Miljkovic, Branislava
    Radovanovic, Slavica
    PHARMACOTHERAPY, 2016, 36 (07): : E87 - E87
  • [9] Prevalence and predictors of potential drug-drug interactions
    Nikolic, Bozana
    Jankovic, Slobodan
    Stojanov, Oliver
    Popovic, Jovan
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (02): : 348 - 356
  • [10] Prevalence of Potential Drug-Drug Interactions in an Intensive Care Unit at a Brazilian Hospital
    Cruciol-Souza, Joice M.
    Ferreira-Filho, Olavo F.
    Obreli-Neto, Paulo R.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (10): : 1469 - 1475
12345